Melbourne, Australia – 30 May 2024 – Oz Medicann Group (OMG) is proud to announce that its subsidiary, OMG Pharma, has won the prestigious Cannabiz Award for Best Product Launch 2024 for its Unwind Topical Pain Relief Salves. The awards ceremony, held in front of a sold-out audience in Melbourne, recognised the most innovative and impactful products in the cannabis industry.
The Cannabiz Awards were judged by 35 senior industry figures through a rigorous two-stage process, ensuring the highest standards of evaluation. The judges praised OMG Pharma for its unwavering commitment to clinical evidence and scientific rigour in all its endeavours. Specifically, the OMG Topical Pain Relief Salve was recognised for its effectiveness in treating rheumatoid arthritis, as well as joint and muscle pain.
A note from John McKenzie Leith
John McKenzie Leith, Founder and CEO of Oz Medicann Group, expressed his gratitude for the recognition: “We are honoured to receive this award and be acknowledged by such a distinguished panel of judges. Our Unwind Topical Pain Relief Salves represent our dedication to developing innovative, science-backed solutions that improve the quality of life for our customers.”
The Unwind Topical Pain Relief Salve has set a new benchmark in the industry, offering a natural, effective treatment for those suffering from chronic pain conditions. This award underscores OMG Pharma’s mission to deliver top-quality, evidence-based cannabinoid products to the market.
About OMG Pharma Australia
OMG Pharma Australia, the science division of the Oz Medicann Group, leads cannabinoid medicine research, drug development and product innovation. For more information visit omgpharma.com.au.
Media contact: info@ozmedicann.com